000 04526nam a22003975i 4500
001 279823
003 MX-SnUAN
005 20160429153959.0
007 cr nn 008mamaa
008 150903s2008 xxu| o |||| 0|eng d
020 _a9780387689692
_99780387689692
024 7 _a10.1007/9780387689692
_2doi
035 _avtls000331962
039 9 _a201509030203
_bVLOAD
_c201404121959
_dVLOAD
_c201404091726
_dVLOAD
_y201402041017
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aRC261-271
100 1 _aCoukos, George.
_eeditor.
_9304359
245 1 0 _aOvarian Cancer :
_bState of the Art and Future Directions in Translational Research /
_cedited by George Coukos, Andrew Berchuck, Robert Ozols.
264 1 _aNew York, NY :
_bSpringer New York,
_c2008.
300 _brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
490 0 _aAdvances in Experimental Medicine and Biology,
_x0065-2598 ;
_v622
500 _aSpringer eBooks
505 0 _aOvarian Cancer Detection and Pathogenesis -- Potential and Limitations in Early Diagnosis of Ovarian Cancer -- SMRP and HE4 as Biomarkers for Ovarian Carcinoma When Used Alone and in Combination with CA125 and/or Each Other -- Classification of Ovarian Cancer: A Genomic Analysis -- Epigenetic Markers of Ovarian Cancer -- Role of Genetic Polymorphisms in Ovarian Cancer Susceptibility: Development of an International Ovarian Cancer Association Consortium -- MicroRNA in Human Cancer: One Step Forward in Diagnosis and Treatment -- Ovarian Carcinogenesis: An Alternative Hypothesis -- BRCA1-Induced Ovarian Oncogenesis -- Role of p53 and Rb in Ovarian Cancer -- Ovulatory Factor in Ovarian Carcinogenesis -- Ovarian Cancer Therapeutics -- Gynecologic Oncology Group (GOG-USA) Trials in Ovarian Cancer -- Intraperitoneal Chemotherapy for Ovarian Cancer -- Ovarian Cancer: Can We Reverse Drug Resistance? -- Syngeneic Mouse Model of Epithelial Ovarian Cancer: Effects of Nanoparticulate Paclitaxel, Nanotax® -- Individualized Molecular Medicine: Linking Functional Proteomics to Select Therapeutics Targeting the PI3K Pathway for Specific Patients -- Defective Apoptosis Underlies Chemoresistance in Ovarian Cancer -- Nanoparticle Delivery of Suicide DNA for Epithelial Ovarian Cancer Therapy -- Biological Therapy with Oncolytic Herpesvirus -- Cancer Immunotherapy: Perspectives and Prospects -- Regulatory T Cells: A New Frontier in Cancer Immunotherapy -- Inhibitory B7 Family Members in Human Ovarian Carcinoma -- Role of Vascular Leukocytes in Ovarian Cancer Neovascularization -- Heparin-Binding Epidermal Growth Factor-Like Growth Factor as a New Target Molecule for Cancer Therapy.
520 _aAegean Conferences is an independent, nonprofit, educational organization directed and managed by the scientific community. The board is made up of nine researchers/scientists in various disciplines from Harvard, Brown, University of Pennsylvania, UCSD, Princeton, Biovista and the Foundation for Biomedical Research Academy of Athens. The board both invites and approves unsolicited proposals for Conferences in all fields of Science, Engineering, Arts, and Humanities. The purpose of the Conferences is to bring together individuals with common interests to examine the emerging and most advanced aspects of their particular field. The Symposium on Ovarian Cancer: State of the Art and Future Directions intends to bring together international experts interested in the development of novel diagnostic, prognostic and therapeutic tools for ovarian cancer. The meeting will function as a think tank where clinicians, translational and basic scientists, and parties from the biotechnology and pharmaceutical industry will get together to review recent advances in clinical research and translational science in ovarian cancer and define areas of future research opportunities and priorities.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700 1 _aBerchuck, Andrew.
_eeditor.
_9304360
700 1 _aOzols, Robert.
_eeditor.
_9304361
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9780387689661
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-0-387-68969-2
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c279823
_d279823